Literature DB >> 30396836

Validation of the French 3-year prognostic score using the Canadian Cystic Fibrosis registry.

Adèle Coriati1, Jenna Sykes2, Lionelle Nkam3, Mounia N Hocine4, Pierre-Régis Burgel5, Anne L Stephenson6.   

Abstract

Studies of large CF populations using registry data are important to identify people at high risk for death. Nkam et al. published a prognostic score developed on French CF registry data to predict death or lung transplantation (LT) over a 3-year period in the adult CF population. The goal of our study was to validate the proposed tool using the Canadian CF registry. Using data between 2011 and 2014, a total of 2043 adult CF patients were included. We found that the French prognostic score was a good predictor of death or LT in the Canadian CF population (OR for each unit increase: 3.12, 95% CI: 2.74-3.55; p value < 0.001). The proposed prognostic score accurately categorizes patients when applied to an external dataset. This score provides an important tool for early identification of patients at high risk for death or LT, in whom specific therapeutic intervention can be proposed.
Copyright © 2018 European Cystic Fibrosis Society. Published by Elsevier B.V. All rights reserved.

Entities:  

Keywords:  Data registry; Death; Lung transplantation; Predictive score

Year:  2018        PMID: 30396836     DOI: 10.1016/j.jcf.2018.10.014

Source DB:  PubMed          Journal:  J Cyst Fibros        ISSN: 1569-1993            Impact factor:   5.482


  2 in total

1.  Quantification of Cystic Fibrosis Lung Disease with Radiomics-based CT Scores.

Authors:  Guillaume Chassagnon; Evangelia I Zacharaki; Sébastien Bommart; Pierre-Régis Burgel; Raphael Chiron; Séverine Dangeard; Nikos Paragios; Clémence Martin; Marie-Pierre Revel
Journal:  Radiol Cardiothorac Imaging       Date:  2020-12-17

Review 2.  The future of cystic fibrosis care: a global perspective.

Authors:  Scott C Bell; Marcus A Mall; Hector Gutierrez; Milan Macek; Susan Madge; Jane C Davies; Pierre-Régis Burgel; Elizabeth Tullis; Claudio Castaños; Carlo Castellani; Catherine A Byrnes; Fiona Cathcart; Sanjay H Chotirmall; Rebecca Cosgriff; Irmgard Eichler; Isabelle Fajac; Christopher H Goss; Pavel Drevinek; Philip M Farrell; Anna M Gravelle; Trudy Havermans; Nicole Mayer-Hamblett; Nataliya Kashirskaya; Eitan Kerem; Joseph L Mathew; Edward F McKone; Lutz Naehrlich; Samya Z Nasr; Gabriela R Oates; Ciaran O'Neill; Ulrike Pypops; Karen S Raraigh; Steven M Rowe; Kevin W Southern; Sheila Sivam; Anne L Stephenson; Marco Zampoli; Felix Ratjen
Journal:  Lancet Respir Med       Date:  2019-09-27       Impact factor: 30.700

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.